Xiong Y D, Ma S, Li X, Zhong X, Duan C, Chen Q
Department of Epidemiology, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, China.
Guangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.
J Eur Acad Dermatol Venereol. 2016 Aug;30(8):1295-302. doi: 10.1111/jdv.13712. Epub 2016 May 27.
Early diagnosis is extremely important for treatment and prognosis of skin cancer. Reflectance confocal microscopy (RCM) is a recently developed technique used to diagnose skin cancer. This meta-analysis was carried out to assess the accuracy of RCM for the diagnosis of malignant skin tumours. We conducted a systematic literature search of EMBASE, PubMed, the Cochrane Library and Web of Science database for relevant articles in English published up to 24 December 2015. The quality of the included studies was assessed using the QUADAS-2 tool. Statistical analyses were conducted using the software Meta-Disc version 1.4 and STATA version 12.0. A total of 21 studies involving 3108 patients with a total of 3602 lesions were included in the per-lesion analysis. The corresponding pooled results for sensitivity and specificity were 93.6% (95% CI: 0.92-0.95) and 82.7% (95% CI: 0.81-0.84) respectively. Positive likelihood ratio and negative likelihood ratio were 5.84 (95% CI: 4.27-7.98) and 0.08 (95% CI: 0.07-0.10) respectively. Subgroup analysis showed that RCM had a sensitivity of 92.7% (95% CI: 0.90-0.95) and a specificity of 78.3% (95% CI: 0.76-0.81) for detecting melanoma. The pooled sensitivity and specificity of RCM for detecting basal cell carcinoma were 91.7% (95% CI: 0.87-0.95) and 91.3% (95% CI: 0.94-0.96) respectively. RCM is a valid method of identifying malignant skin tumours accurately.
早期诊断对于皮肤癌的治疗和预后极为重要。反射式共聚焦显微镜(RCM)是一种最近开发用于诊断皮肤癌的技术。本荟萃分析旨在评估RCM诊断恶性皮肤肿瘤的准确性。我们对EMBASE、PubMed、Cochrane图书馆和科学网数据库进行了系统的文献检索,以查找截至2015年12月24日发表的相关英文文章。使用QUADAS - 2工具评估纳入研究的质量。使用Meta - Disc 1.4版软件和STATA 12.0版软件进行统计分析。在按病变分析中,共纳入了21项研究,涉及3108例患者,总共3602个病变。敏感性和特异性的相应合并结果分别为93.6%(95%CI:0.92 - 0.95)和82.7%(95%CI:0.81 - 0.84)。阳性似然比和阴性似然比分别为5.84(95%CI:4.27 - 7.98)和0.08(95%CI:0.07 - 0.10)。亚组分析表明,RCM检测黑色素瘤的敏感性为92.7%(95%CI:0.90 - 0.95),特异性为78.3%(95%CI;0.76 -
81)。RCM检测基底细胞癌的合并敏感性和特异性分别为91.7%(95%CI:0.87 - 0.95)和91.3%(95%CI:0.94 - 0.96)。RCM是一种准确识别恶性皮肤肿瘤的有效方法。